Manske Wealth Management’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$555K Sell
2,186
-443
-17% -$103K 0.14% 125
2026
Q1
$643K Buy
2,629
+171
+7% +$39.8K 0.18% 98
2025
Q4
$509K Buy
2,458
+227
+10% +$44.9K 0.15% 114
2025
Q3
$414K Buy
2,231
+13
+0.6% +$2.23K 0.13% 128
2025
Q2
$339K Buy
2,218
+16
+0.7% +$2.46K 0.11% 135
2025
Q1
$365K Buy
2,202
+153
+7% +$23.9K 0.14% 123
2024
Q4
$296K Buy
+2,049
New +$318K 0.12% 134

Other funds holding JNJ

Manske Wealth Management's JNJ Position: Q2 2026 in Review

Manske Wealth Management reduced its Johnson & Johnson (JNJ) stake by 17% in Q2 2026, selling an estimated $103K and leaving 2,186 shares worth $555K. The position accounts for 0.14% of the portfolio, ranked #125.

Manske Wealth Management first reported a position in JNJ in Q4 2024 and has held it in 7 quarters since. The position peaked at $643K in Q1 2026. 4,656 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Manske Wealth Management held 2,186 shares of Johnson & Johnson worth $555K as of Q2 2026.
  • Manske Wealth Management sold 443 Johnson & Johnson shares in Q2 2026, an estimated $103K.
  • Johnson & Johnson made up 0.14% of Manske Wealth Management's portfolio in Q2 2026, its #125 holding.
  • Manske Wealth Management first reported a position in Johnson & Johnson in Q4 2024 and has held it in 7 quarters since.
  • Manske Wealth Management's Johnson & Johnson position peaked at $643K in Q1 2026.
  • 4,656 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Manske Wealth Management's 13F filing for Q2 2026, filed 3 Aug 2026.